15340492_33|15340492|7132|#section_info|0:160|The RNAi of elo-6 significantly reduced the amount of only C17ISO, while the RNAi of elo-5 dramatically reduced quantities of both C15ISO and C17ISO (Figure 3).|#main_body|GO:1902321||#go_definition|IGI|GOA|elo-5(177320)|#gene_synonym
15340492_57|15340492|8309|#section_info|510:608|RNAi of Y39E4A.3 led to a significant decrease in C15ISO and C17ISO production (Figure 4B and 4C).|#main_body|GO:1902321||#go_definition|IPI|GOA|Y39E4A.3(176716)|#gene_synonym
15340492_59|15340492|8309|#section_info|609:862|RNAi suppression of another predicted component of the BCKAD complex, pyruvate dehydrogenase (T05H10.6), resulted in a similar decrease in C15ISO and C17ISO (unpublished data), indicating a role for the  BCKAD protein in long-chain mmBCFA biosynthesis. |#main_body|GO:1902321||#go_definition|IGI|GOA|T05H10.6(3565996)|#gene_synonym
15340492_73|15340492|9917|#section_info|0:63|Blocking ELO-5 Function Causes Growth and Developmental Defects|#main_body|GO:0035264|multicellular organism growth|#go_definition|IGI|GOA|elo-5(177320)|#gene_synonym
15340492_75|15340492|9917|#section_info|0:63|Blocking ELO-5 Function Causes Growth and Developmental Defects|#main_body|GO:0010259|multicellular organism aging|#go_definition|IEP|GOA|elo-5(177320)|#gene_synonym
15340492_77|15340492|9981|#section_info|231:747|Worms originating from wild-type eggs laid on the elo-5(RNAi) plates displayed no obvious growth or morphological abnormality until the second day of adulthood, when they developed an egg-laying defect (Figure 5B). Eggs of the next generation hatched on time but the progeny arrested at the first of the four larval stages (L1). The small larvae maintained morphological integrity and could survive on a plate for up to 3-4 d. The arrest was only observed in progeny of parents exposed to elo-5 RNAi at the L1 stage.|#main_body|GO:0061067|negative regulation of dauer larval development|Any process that decreases the rate, frequency, or extent of nematode larval development, the process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.|IPI|GOA|elo-5(177320)|#gene_synonym
15340492_79|15340492|10729|#section_info|820:1023|The development of the elo-5 RNAi phenotypes is likely due to a gradual elimination of the ELO-5-associated functions. Our data suggest that these functions are crucial for larval growth and development.|#main_body|GO:0090446|negative regulation of nematode larval development, heterochronic|Any process that decreases the rate, frequency, or extent of nematode larval development, the process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.|IGI|GOA|elo-5(177320)|#gene_synonym
15340492_81|15340492|10729|#section_info|0:158$$404:538|When parental animals were subjected to elo-5 RNAi at later larval stages (L2-L4), their progeny did not arrest in L1 but continued to develop into adulthood. The gonads appeared normal at the L4 and early adult stages, but after fertilization of one to ten oocytes, oogenesis became impaired.|#main_body|GO:0048477|oogenesis|#go_definition|IPI|GOA|elo-5(177320)|#gene_synonym
15340492_83|15340492|10729|#section_info|0:158$$709:819|When parental animals were subjected to elo-5 RNAi at later larval stages (L2-L4), their progeny did not arrest in L1 but continued to develop into adulthood. An egg-laying defect became apparent and only a few progeny arose from these worms, which then arrested at L1.|#main_body|GO:0018991|oviposition|#go_definition|IDA|GOA|elo-5(177320)|#gene_synonym
15340492_85|15340492|10729|#section_info|0:158$$709:819|When parental animals were subjected to elo-5 RNAi at later larval stages (L2-L4), their progeny did not arrest in L1 but continued to develop into adulthood. An egg-laying defect became apparent and only a few progeny arose from these worms, which then arrested at L1.|#main_body|GO:0090446|negative regulation of nematode larval development, heterochronic|Any process that decreases the rate, frequency, or extent of nematode larval development, the process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.|IDA|GOA|elo-5(177320)|#gene_synonym
15340492_87|15340492|11753|#section_info|0:300|We also obtained a likely null mutant of the elo-5 gene, elo-5(gk208), which has a 245-bp deletion eliminating the predicted first exon (Genome Science Center, BC Cancer Research Center, Vancouver, British Columbia, Canada). This allele phenocopies the L1 arrest phenotype of the elo-5(RNAi) animals.|#main_body|GO:0061067|negative regulation of dauer larval development|Any process that decreases the rate, frequency, or extent of nematode larval development, the process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.|IGI|GOA|elo-5(177320)|#gene_synonym
15340492_89|15340492|12054|#section_info|0:97|A Deficiency of C15ISO and C17ISO FAs Is Solely Responsible for the Defects Caused by elo-5(RNAi)|#main_body|GO:1902321||#go_definition|IEP|GOA|elo-5(177320)|#gene_synonym
15340492_91|15340492|12152|#section_info|272:533|As predicted, the C17ISO and C17anteISO supplements rescued the elo-5 RNAi defects (in 52 of 60 and 58 of 60 plates, respectively). A partial rescue was observed on the plates supplemented with C15ISO and C15anteISO (23 of 38 and 20 of 28 plates, respectively).|#main_body|GO:1902321||#go_definition|IEP|GOA|elo-5(177320)|#gene_synonym
15340492_93|15340492|12152|#section_info|534:642|Corroborating results were obtained when homozygous elo-5(gk208) animals supplied with C17ISO grew normally.|#main_body|GO:1902321||#go_definition|IGI|GOA|elo-5(177320)|#gene_synonym
15340492_95|15340492|12152|#section_info|937:1083|Therefore, we have determined that only dietary 17-carbon mmBCFAs are competent to bypass the biochemical defect caused by loss of ELO-5 function.|#main_body|GO:1902321||#go_definition|IEP|GOA|elo-5(177320)|#gene_synonym
15340492_97|15340492|15019|#section_info|0:406|The essential roles of C15ISO and C17ISO were also supported through an examination of the elo-5(gk208) deletion mutant. The homozygous mutants grew without any obvious morphological defects when maintained on the plates supplemented with C17ISO or seeded with S. maltophilia. However, removal of the FA supplements or  by bleaching resulted in the same L1 arrest phenotype seen for the elo-5(RNAi) worms.|#main_body|GO:1902321||#go_definition|IDA|GOA|elo-5(177320)|#gene_synonym
15340492_99|15340492|15019|#section_info|0:406|The essential roles of C15ISO and C17ISO were also supported through an examination of the elo-5(gk208) deletion mutant. The homozygous mutants grew without any obvious morphological defects when maintained on the plates supplemented with C17ISO or seeded with S. maltophilia. However, removal of the FA supplements or  by bleaching resulted in the same L1 arrest phenotype seen for the elo-5(RNAi) worms.|#main_body|GO:0090446|negative regulation of nematode larval development, heterochronic|Any process that decreases the rate, frequency, or extent of nematode larval development, the process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.|IGI|GOA|elo-5(177320)|#gene_synonym
15340492_101|15340492|15425|#section_info|0:119|L1 Arrest of the elo-5(RNAi) Animals Is Reversible and Related to the Variations in Levels of C17ISO during Development|#main_body|GO:0040027|negative regulation of vulval development|Any process that decreases the rate, frequency, or extent of nematode larval development, the process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.|IPI|GOA|elo-5(177320)|#gene_synonym
15340492_103|15340492|15545|#section_info|0:315|We then asked if elo-5(RNAi) animals arrested at the L1 stage could be recovered by adding the 17-carbon mmBCFA supplements. Indeed, C17ISO and C17anteISO could effectively release L1 larvae from the developmental arrest; about 50% of 2-d-arrested and 1% of 4-d-old L1 were rescued to full growth and proliferation.|#main_body|GO:1902321||#go_definition|IPI|GOA|elo-5(177320)|#gene_synonym
15340492_105|15340492|15545|#section_info|0:315|We then asked if elo-5(RNAi) animals arrested at the L1 stage could be recovered by adding the 17-carbon mmBCFA supplements. Indeed, C17ISO and C17anteISO could effectively release L1 larvae from the developmental arrest; about 50% of 2-d-arrested and 1% of 4-d-old L1 were rescued to full growth and proliferation.|#main_body|GO:0061067|negative regulation of dauer larval development|Any process that decreases the rate, frequency, or extent of nematode larval development, the process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.|IEP|GOA|elo-5(177320)|#gene_synonym
15340492_107|15340492|16226|#section_info|671:947|When RNAi-mediated disruption of elo-5 occurs at the L1 stage of a parent and consequently blocks C17ISO synthesis from that stage on, the eggs and L1 animals of the next generation are expected to contain a critically low concentration of C17ISO, halting further development.|#main_body|GO:1902321||#go_definition|IGI|GOA|elo-5(177320)|#gene_synonym
15340492_109|15340492|16226|#section_info|671:947|When RNAi-mediated disruption of elo-5 occurs at the L1 stage of a parent and consequently blocks C17ISO synthesis from that stage on, the eggs and L1 animals of the next generation are expected to contain a critically low concentration of C17ISO, halting further development.|#main_body|GO:0061067|negative regulation of dauer larval development|Any process that decreases the rate, frequency, or extent of nematode larval development, the process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.|IEP|GOA|elo-5(177320)|#gene_synonym
15340492_111|15340492|17357|#section_info|0:419|If elo-5 RNAi is applied to the parent worms at or after the L2 larval stage, when the amount of C17ISO has already been elevated and/or the RNAi effect is less penetrant, the progeny may receive sufficient C17ISO to pass the L1 arrest stage. The resulting animals, however, become visibly unhealthy at the L4 and adult stages as mentioned earlier, suggesting that C17ISO also plays a role in late developmental stages.|#main_body|GO:0061067|negative regulation of dauer larval development|Any process that decreases the rate, frequency, or extent of nematode larval development, the process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.|IPI|GOA|elo-5(177320)|#gene_synonym
15340492_113|15340492|20014|#section_info|0:238|In the elo-5(RNAi)-treated worms, a substantial loss of C15ISO and C17ISO is also accompanied by a change in the FA composition, most noticeably by the elevation in C18:1 n7 (see Figure 3C), a result consistent with the above observation.|#main_body|GO:1902321||#go_definition|IPI|GOA|elo-5(177320)|#gene_synonym
15340492_115|15340492|20014|#section_info|0:238|In the elo-5(RNAi)-treated worms, a substantial loss of C15ISO and C17ISO is also accompanied by a change in the FA composition, most noticeably by the elevation in C18:1 n7 (see Figure 3C), a result consistent with the above observation.|#main_body|GO:0055089|fatty acid homeostasis|#go_definition|IEP|GOA|elo-5(177320)|#gene_synonym
15340492_121|15340492|22796|#section_info|66:655|We first applied RNAi to lpd-1 and determined the FA composition of the mutant worms. As expected, the FA content of treated animals was significantly changed, but surprisingly the most reduced were the levels of C15ISO and C17ISO (Figure 9). Also significantly reduced was the amount of C18:2 n6. In contrast, the C16:0 level was elevated. These data indicate that, in addition to regulating the first steps of global FA biosynthesis through the activation of the ACC and FAS transcription, the worm SREBP homolog regulates mmBCFA elongation as well as desaturation of straight-chain FAs.|#main_body|GO:1902324|positive regulation of methyl-branched fatty acid biosynthetic process|#go_definition|IDA|GOA|lpd-1(176574)|#gene_synonym
15340492_123|15340492|22796|#section_info|66:655|We first applied RNAi to lpd-1 and determined the FA composition of the mutant worms. As expected, the FA content of treated animals was significantly changed, but surprisingly the most reduced were the levels of C15ISO and C17ISO (Figure 9). Also significantly reduced was the amount of C18:2 n6. In contrast, the C16:0 level was elevated. These data indicate that, in addition to regulating the first steps of global FA biosynthesis through the activation of the ACC and FAS transcription, the worm SREBP homolog regulates mmBCFA elongation as well as desaturation of straight-chain FAs.|#main_body|GO:2001280|positive regulation of unsaturated fatty acid biosynthetic process|#go_definition|IGI|GOA|lpd-1(176574)|#gene_synonym
15340492_125|15340492|23452|#section_info|129:330|The effect of lpd-1 RNAi feeding in our experiments was apparently less severe. The RNAi-treated animals displayed slow growth, morphological abnormalities, and egg-laying defects but no larval arrest.|#main_body|GO:0040015|negative regulation of multicellular organism growth|Any process that stops, prevents, or reduces the frequency, rate or extent of growth of an organism to reach its usual body size.|IGI|GOA|lpd-1(176574)|#gene_synonym
15340492_127|15340492|23452|#section_info|129:330|The effect of lpd-1 RNAi feeding in our experiments was apparently less severe. The RNAi-treated animals displayed slow growth, morphological abnormalities, and egg-laying defects but no larval arrest.|#main_body|GO:0010172|embryonic body morphogenesis|#go_definition|IDA|GOA|lpd-1(176574)|#gene_synonym
15340492_129|15340492|23452|#section_info|129:330|The effect of lpd-1 RNAi feeding in our experiments was apparently less severe. The RNAi-treated animals displayed slow growth, morphological abnormalities, and egg-laying defects but no larval arrest.|#main_body|GO:0018991|oviposition|#go_definition|IEP|GOA|lpd-1(176574)|#gene_synonym
15340492_135|15340492|25012|#section_info|0:250|The changes in FA composition observed in lpd-1(RNAi) would be consistent with downregulation of elo-5, elo-6 (decrease in mmBCFA), elo-2 (increase in C16:0) (Kniazeva et al. 2003), and Delta9- and/or Delta12-desaturase genes (decrease in C18:2 n6). |#main_body|GO:1902322|regulation of methyl-branched fatty acid biosynthetic process|#go_definition|IPI|GOA|lpd-1(176574)|#gene_synonym
15340492_137|15340492|26198|#section_info|255:418|In the worms maintained on the lpd-1(RNAi) plates, the expression was noticeably weakened, suggesting a downregulation of the promoter activities (Figure 11A-11D).|#main_body|GO:0000433|carbon catabolite repression of transcription from RNA polymerase II promoter by glucose|Any process involving glucose that decreases the frequency, rate or extent or transcription from an RNA polymerase II promoter.|IPI|GOA|lpd-1(176574)|#gene_synonym
15340492_139|15340492|26813|#section_info|0:200|To test if the disruption of FAS, a target of LPD-1 (McKay et al. 2003), could contribute to the observed decrease of C15ISO and C17ISO in lpd-1(RNAi), we analyzed FA composition in FAS(RNAi) strains.|#main_body|GO:1902324||#go_definition|IEP|GOA|lpd-1(176574)|#gene_synonym
15340492_145|15340492|26813|#section_info|931:1047|Therefore, downregulation of FAS by loss of lpd-1 cannot account for the severe deficiency of mmBCFA in lpd-1(RNAi).|#main_body|GO:1902324||#go_definition|IPI|GOA|lpd-1(176574)|#gene_synonym
15340492_147|15340492|27861|#section_info|0:84|Thus, we have shown that disruption of lpd-1 affects C15ISO and C17ISO biosynthesis.|#main_body|GO:1902324|positive regulation of methyl-branched fatty acid biosynthetic process|#go_definition|IGI|GOA|lpd-1(176574)|#gene_synonym
15340492_149|15340492|27861|#section_info|85:357|The fact that lpd-1, elo-5, and elo-6 are expressed in the same cells concurrently and that the GFP reporter analysis indicated that elo-5 and elo-6 transcription is downregulated in the absence of lpd-1 suggests that elo-5 and elo-6 are likely to be the targets of lpd-1.|#main_body|GO:0000433|carbon catabolite repression of transcription from RNA polymerase II promoter by glucose|Any process involving glucose that decreases the frequency, rate or extent or transcription from an RNA polymerase II promoter.|IEP|GOA|lpd-1(176574)|#gene_synonym
15340492_153|15340492|29318|#section_info|699:849|This suggests that a chronic deficiency of mmBCFA in elo-5(RNAi) animals may transcriptionally stimulate LPD-1 production, at least in neuronal cells.|#main_body|GO:1902321||#go_definition|IGI|GOA|elo-5(177320)|#gene_synonym
15340492_165|15340492|31245|#section_info|377:491|RNAi of spt-1 strongly affects the FA composition without reducing the C15ISO or C17ISO levels (unpublished data).|#main_body|GO:0006633|fatty acid biosynthetic process|#go_definition|IPI|GOA|sptl-1(173389)|#gene_synonym
15340492_167|15340492|31245|#section_info|492:726|The F1 generation of spt-1(RNAi) animals developed gonadal and egg-laying defects that were similar to the phenotype of F1 animals from parents treated with elo-5(RNAi) at a late larval stage (described earlier; see Figure 5B and 5F).|#main_body|GO:0040035|hermaphrodite genitalia development|#go_definition|IDA|GOA|sptl-1(173389)|#gene_synonym
15340492_169|15340492|31245|#section_info|492:726|The F1 generation of spt-1(RNAi) animals developed gonadal and egg-laying defects that were similar to the phenotype of F1 animals from parents treated with elo-5(RNAi) at a late larval stage (described earlier; see Figure 5B and 5F).|#main_body|GO:0018991|oviposition|#go_definition|IPI|GOA|sptl-1(173389)|#gene_synonym
15340492_171|15340492|32418|#section_info|159:309|RNAi of four of these genes (pnk-1 [C10G11.5], nhr-49 [K10C3.6], acs-1 [F46E10.1], and C27H6.2) significantly affected the FA composition (Figure 12).|#main_body|GO:0031407|oxylipin metabolic process|#go_definition|IGI|GOA|pnk-1(172327)|#gene_synonym
15340492_187|15340492|32990|#section_info|438:629|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi).|#main_body|GO:1902321||#go_definition|IDA|GOA|elo-5(177320)|#gene_synonym
15340492_189|15340492|32990|#section_info|438:800|Second, the direction of the changes for three of the genes is in concordance with the proposed feedback regulation: pnk-1, nhr-49, and acs-1 were upregulated in C17ISO-deficient elo-5(RNAi). Lastly, a functional analysis shows that these three candidate genes are required for the normal level of mmBCFA production (RNAi of the genes affects mmBCFA production).|#main_body|GO:1902321||#go_definition|IGI|GOA|pnk-1(172327)|#gene_synonym
15340492_201|15340492|33954|#section_info|617:877|A comparison of synchronized animals grown on the control and elo-5(RNAi) plates indicated a significantly brighter fluorescence in the RNAi worms (see Figure 11I, 11J, 11L, and 11M), suggesting upregulation of acs-1and pnk-1 under C15ISO or C17ISO deficiency.|#main_body|GO:1902321||#go_definition|IEP|GOA|elo-5(177320)|#gene_synonym
15340492_203|15340492|33954|#section_info|938:1102|Moreover, pnk-1, but not acs-1, seemed to be regulated by LPD-1 because pnk-1Prom::GFP expression was significantly reduced on lpd-1(RNAi) (see Figure 11L and 11N).|#main_body|GO:0000433|carbon catabolite repression of transcription from RNA polymerase II promoter by glucose|Any process involving glucose that decreases the frequency, rate or extent or transcription from an RNA polymerase II promoter.|IGI|GOA|lpd-1(176574)|#gene_synonym
15340492_205|15340492|33954|#section_info|0:404|To detect potential feedback regulation involving acs-1 and pnk-1, we made reporter strains with GFP expression driven by acs-1 and pnk-1 promoters, acs-1Prom::GFP and pnk-1Prom::GFP, respectively. These two genes showed a higher degree of upregulation than the other candidates according to the microarray data. In addition, RNAi of these two genes resulted in a significant loss in the mmBCFA fraction.|#main_body|GO:1902321||#go_definition|IPI|GOA|pnk-1(172327)|#gene_synonym
15340492_209|15340492|35068|#section_info|752:923|Our analysis of nhr-49(RNAi) animals showed that reduction of nhr-49 activity results in upregulation of saturated FA biosynthesis that may contribute to fat accumulation.|#main_body|GO:1902324|positive regulation of methyl-branched fatty acid biosynthetic process|Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of fatty acids.|IEP|GOA|nhr-49(172839)|#gene_synonym
15340492_211|15340492|36717|#section_info|0:132|Downregulation of the fourth candidate gene, C27H6.2, may result in a significant increase in monounsaturated FA levels (Figure 12).|#main_body|GO:0043651|linoleic acid metabolic process|#go_definition|IGI|GOA|C27H6.2(179388)|#gene_synonym
15340492_213|15340492|36717|#section_info|133:254|This is consistent with the enlarged fraction of monounsaturated FAs observed in the elo-5(RNAi) animals (see Figure 3C).|#main_body|GO:0051121|hepoxilin metabolic process|#go_definition|IPI|GOA|elo-5(177320)|#gene_synonym
15340492_219|15340492|52654|#section_info|0:181|(C) Comparison of FA composition in three strains: wild type, elo-5(RNAi), and elo-6(RNAi). C17ISO is decreased in both RNAi strains, while C15ISO is only decreased in elo-5(RNAi).|#fig_caption|GO:1902321||#go_definition|IDA|GOA|elo-5(177320)|#gene_synonym
15340492_247|15340492|53560|#section_info|0:162|(B) GC profiles reveal differences in the FA composition in the wild-type animals and animals treated with RNAi of E1 alpha subunit of BCKAD encoded by Y39E4A.3. |#fig_caption|GO:2001132|methane biosynthetic process from 3-(methylthio)propionic acid|#go_definition|IEP|GOA|Y39E4A.3(176716)|#gene_synonym
15340492_249|15340492|53767|#section_info|0:192|(C) A summary of several independent preparations shows a significant decrease in both mmBCFAs in the Y39E4A.3 dsRNA-treated animals (p = 0.001 and 0.008 for C15ISO and C17ISO, respectively).|#fig_caption|GO:1902321||#go_definition|IDA|GOA|Y39E4A.3(176716)|#gene_synonym
15340492_251|15340492|53959|#section_info|0:72|RNAi Treatment of elo-5 Causes L1 Arrest and Other Physiological Defects|#main_body|GO:0061067|negative regulation of dauer larval development|Any process that decreases the rate, frequency, or extent of nematode larval development, the process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.|IPI|GOA|elo-5(177320)|#gene_synonym
15340492_253|15340492|54180|#section_info|0:180|(B) On the second day of adulthood, these animals displayed an egg-laying defect; eggs hatched inside the worms. Arrows point to the late embryos and hatched larvae inside a worm.|#fig_caption|GO:0018991|oviposition|#go_definition|IPI|GOA|elo-5(177320)|#gene_synonym
15340492_255|15340492|54360|#section_info|0:105|(C) F1 generation arrested uniformly at the first larval stage (L1), and larvae arrested for 4-5 d died.|#fig_caption|GO:0090446|negative regulation of nematode larval development, heterochronic|Any process that decreases the rate, frequency, or extent of nematode larval development, the process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.|IGI|GOA|elo-5(177320)|#gene_synonym
15340492_257|15340492|54547|#section_info|0:144|(D) The F1 progeny of worms developed from the treated larvae had smaller size and a scrawny morphology compared to the wild type shown in (A). |#fig_caption|GO:0040015|negative regulation of multicellular organism growth|Any process that stops, prevents, or reduces the frequency, rate or extent of growth of an organism to reach its usual body size.|IPI|GOA|elo-5(177320)|#gene_synonym
15340492_259|15340492|54711|#section_info|0:94|(E) These animals produced very few oocytes, some of which gave rise to embryos and L1 worms. |#fig_caption|GO:0048477|oogenesis|#go_definition|IPI|GOA|elo-5(177320)|#gene_synonym
15340492_261|15340492|54905|#section_info|0:84|(F) The proximal part of the gonads undergoes deterioration resulting in sterility. |#fig_caption|GO:0019953|sexual reproduction|#go_definition|IGI|GOA|elo-5(177320)|#gene_synonym
15340492_263|15340492|55390|#section_info|0:172|(A) Animals grown with C15ISO supplements were partially rescued to the wild-type phenotype; however, no accumulation of C15ISO or its elongation to C17ISO was detectable.|#fig_caption|GO:1902321||#go_definition|IGI|GOA|elo-5(177320)|#gene_synonym
15340492_265|15340492|55562|#section_info|0:154|(B and C) Animals grown with the (B) C17ISO or (C) C17anteISO supplements were fully rescued. Peaks corresponding to C17ISO and C17anteISO are prominent.|#fig_caption|GO:1902321||#go_definition|IEP|GOA|elo-5(177320)|#gene_synonym
15340492_267|15340492|56314|#section_info|173:432|If elo-5 is suppressed in parental animals after they have begun to synthesize mmBCFA, then their eggs will have a reduced C17ISO level that is still above the critical low level, which permits these animals to grow but causes them to display gonadal defects.|#fig_caption|GO:0008585|female gonad development|#go_definition|IPI|GOA|elo-5(177320)|#gene_synonym
15340492_269|15340492|56314|#section_info|173:432|If elo-5 is suppressed in parental animals after they have begun to synthesize mmBCFA, then their eggs will have a reduced C17ISO level that is still above the critical low level, which permits these animals to grow but causes them to display gonadal defects.|#fig_caption|GO:1902321||#go_definition|IPI|GOA|elo-5(177320)|#gene_synonym
15340492_271|15340492|56314|#section_info|173:507|If elo-5 is suppressed in parental animals after they have begun to synthesize mmBCFA, then their eggs will have a reduced C17ISO level that is still above the critical low level, which permits these animals to grow but causes them to display gonadal defects. These worms produce a small number of progeny that is then arrested in L1.|#fig_caption|GO:0090446|negative regulation of nematode larval development, heterochronic|Any process that decreases the rate, frequency, or extent of nematode larval development, the process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.|IDA|GOA|elo-5(177320)|#gene_synonym
15340492_273|15340492|56314|#section_info|508:762|If parental animals are treated with elo-5(RNAi) right after hatching, they are unable to initiate mmBCFA biosynthesis and the levels of C15ISO and C17ISO in their eggs are reduced to below the critical low level, resulting in L1 arrest of their progeny.|#fig_caption|GO:1902321||#go_definition|IPI|GOA|elo-5(177320)|#gene_synonym
15340492_275|15340492|56314|#section_info|508:762|If parental animals are treated with elo-5(RNAi) right after hatching, they are unable to initiate mmBCFA biosynthesis and the levels of C15ISO and C17ISO in their eggs are reduced to below the critical low level, resulting in L1 arrest of their progeny.|#fig_caption|GO:0040027|negative regulation of vulval development|Any process that decreases the rate, frequency, or extent of nematode larval development, the process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.|IGI|GOA|elo-5(177320)|#gene_synonym
15340492_277|15340492|57791|#section_info|0:257|(A and B) The GC profiles of (A) wild-type and (B) lpd-1(RNAi)-treated worms.|#fig_caption|GO:1902324|positive regulation of methyl-branched fatty acid biosynthetic process|#go_definition|IDA|GOA|lpd-1(176574)|#gene_synonym
15340492_279|15340492|59117|#section_info|0:80|(A-D) elo-5Prom::GFP expression is downregulated in the lpd-1(RNAi) background. |#fig_caption|GO:0000433|carbon catabolite repression of transcription from RNA polymerase II promoter by glucose|Any process involving glucose that decreases the frequency, rate or extent or transcription from an RNA polymerase II promoter.|IPI|GOA|lpd-1(176574)|#gene_synonym
15340492_281|15340492|59374|#section_info|0:145|(B and D) GFP-filtered images of (B) elo-5Prom::GFP and (D) elo-5Prom::GFP in lpd-1(RNAi) animals, revealing diminished fluorescence in the gut.|#fig_caption|GO:0000433|carbon catabolite repression of transcription from RNA polymerase II promoter by glucose|Any process involving glucose that decreases the frequency, rate or extent or transcription from an RNA polymerase II promoter.|IEP|GOA|lpd-1(176574)|#gene_synonym
15340492_285|15340492|59519|#section_info|0:109|(E-H) lpd-1 expression is upregulated in neurons of the elo-5(RNAi) animals deficient for C15ISO and C17ISO. |#fig_caption|GO:1902321||#go_definition|IGI|GOA|elo-5(177320)|#gene_synonym
15340492_287|15340492|59732|#section_info|0:177|(G and H) Nomarski and GFP images of elo-5(RNAi)-treated animals (L1 arrested) containing lpd-1Prom::GFP, showing a visibly brighter fluorescence than that seen in (E) and (F). |#fig_caption|GO:0061067|negative regulation of dauer larval development|Any process that decreases the rate, frequency, or extent of nematode larval development, the process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.|IPI|GOA|elo-5(177320)|#gene_synonym
15340492_291|15340492|59959|#section_info|0:107|(I-K) acs-1Prom::GFP expression is upregulated in the elo-5(RNAi) animals deficient for C15ISO and C17ISO. |#fig_caption|GO:1902321||#go_definition|IDA|GOA|elo-5(177320)|#gene_synonym
15340492_293|15340492|60295|#section_info|0:96|(L-N) pnk-1Prom::GFP expression is upregulated by elo-5(RNAi) but downregulated by lpd-1(RNAi). |#fig_caption|GO:0000433|carbon catabolite repression of transcription from RNA polymerase II promoter by glucose|Any process involving glucose that decreases the frequency, rate or extent or transcription from an RNA polymerase II promoter.|IDA|GOA|lpd-1(176574)|#gene_synonym
15340492_297|15340492|60640|#section_info|0:100|RNAi of Four Candidate Genes with Altered Expression in elo-5(RNAi) Worms Affects the FA Composition|#main_body|GO:0033559|unsaturated fatty acid metabolic process|#go_definition|IEP|GOA|pnk-1(172327)|#gene_synonym
15340492_305|15340492|60819|#section_info|0:132|(B-D) RNAi of the three genes resulted in a decrease of the C17ISO or both C15ISO and C17ISO levels, indicated by black arrowheads. |#fig_caption|GO:1902321||#go_definition|IEP|GOA|acs-1(179043)|#gene_synonym
15340492_311|15340492|60819|#section_info|132:267|In addition, a significant elevation in straight-chain saturated FA levels, indicated by grey arrowheads, is observed in K10C3.6(RNAi).|#fig_caption|GO:0071767|mycolic acid metabolic process|#go_definition|IGI|GOA|nhr-49(172839)|#gene_synonym
15340492_313|15340492|61087|#section_info|0:173|(E) C27H6.2(RNAi) does not cause significant changes in mmBCFA but results in an elevation of straight-chain monounsaturated FA and C18:1 n7, indicated by white arrowheads. |#fig_caption|GO:0006633|fatty acid biosynthetic process|#go_definition|IPI|GOA|C27H6.2(179388)|#gene_synonym
